AI / data analytics / healthtech / informatics

AI and robotics
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery

Is AI the answer to the challenges facing drug discovery?

DDW Editor Reece Armstrong asks whether artificial intelligence (AI) is the magic bullet many think it is. To reflect on another year in pharma is to think of the major stories and trends that have made impact within the industry. Often this can be drug approvals, exciting research into hard-to-treat indications, or… Read More

#Exclusive Content #Opinion

2024 predictions, road forward
#2024 predictions #AI / data analytics / healthtech / informatics #Antiverse #Artificial intelligence (AI) #Drug discovery #Elsevier #Enhanc3D Genomics #IQVIA #Lab automation #Machine learning #Medidata #Ori Biotech #Technology #TrakCel #Trinity Life Sciences

2024 predictions: Experts comment on AI, ML and automation

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in… Read More

#Exclusive Content #Opinion #Trends & Analysis

Medicine concept
#AI / data analytics / healthtech / informatics #Animal models #Drug discovery #Genetics / genomics #Synthetic biology

Why have medicines progressed so little in the last decades?

Dr Pandora Pound, Fellow Oxford Centre for Animal Ethics explores the hinderances of animal testing in pharma and why new technologies such AI, genomics and synthetic biology can further drug development.  There was great fanfare recently for a new Alzheimer’s drug, lecanemab (brand name Leqembi), which was shown in a… Read More

#Exclusive Content #Opinion

Boston waterfront
#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #SLAS2024

SLAS2024: Day Two Highlights

Scientific sessions Tuesday’s presentations spanned a range of topics, including functional genomics for target identification, next-generation proteomics, self-driving laboratories, the future of cell culture, and ‘lab on a particle’ technology. There were some great talks on the DDW-hosted Ignite Theater track, co-sponsored by Hamamatsu Corporation and… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automation / robotics #Digitalisation #Lab technology

How digital innovation is helping therapeutics to get to market faster

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and optimising laboratory workflows and… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Genetics / genomics #Multi-omics #SLAS2024

Solving the diagnostic odyssey with multi-omics

Catherine Brownstein is an Assistant Professor in Pediatrics at Harvard Medical School and the Assistant Director of the Molecular Genetics Core Facility at Boston Children's Hospital. Her current work focuses on advancing the fields of genome sequencing and analysis, with an emphasis on identifying complex structural variation. She speaks to… Read More

#Exclusive Content

Boston waterfront
#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #SLAS2024

SLAS2024: Day One Highlights

Opening keynote Following a change to the schedule, Juliet Williams of Kymera Therapeutics launched the event with a popular keynote talk ‘Solving Big Problems with Small Molecule Degraders’. Williams discussed the advantages of the company’s ‘disease agnostic’ small molecule degraders, and its success so far in translating results… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Digital solutions #Generative AI #Machine learning

Siloed use of Gen AI will limit its transformation potential

As long as drug discovery, development and commercialisation activities and budgets continue to be managed in isolation, and Generative AI projects applied in a piecemeal fashion to individual applications, the pharma industry risks inhibiting the technology’s broader potential. Daniel Jamieson, CEO & founder of Biorelate, sets out his vision for… Read More

#Exclusive Content

Boston, MA
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

Join the DDW team at SLAS2024 in Boston

The DDW team is looking forward to meeting you at SLAS2024, Boston, US on 3-7 February. New for this year is the DDW track at the SLAS Ignite Theater, co-sponsored by Integra Biosciences and Hamamatsu Corporation. Industry experts will share their experiences of… Read More

#News

Building blocks concept
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #CRISPR #SLAS2024

The building blocks of AI success stories

Dr Mike Tarselli, Chief Scientific & Knowledge Officer at TetraScience, was Scientific Director of SLAS until 2020, and will be chairing his first event this year. He shares his insight with Megan Thomas. From pharma to non-profit “I probably wouldn’t have the role I have now if I hadn’t worked… Read More

#Exclusive Content

Digital technology concept
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

The journey from lab to patient

By Megan Thomas, DDW Multimedia Editor The last time the DDW team were in Boston for a SLAS event two years ago, the world was very much in the early recovery period of Covid-19. For many, it was their first in-person event – a welcome return. In 2024, with this significant… Read More

#Exclusive Content

Robot holds up a pill
#AI / data analytics / healthtech / informatics #Cancer research #Cell Science #Immunotherapy #Singapore #SLAS2024 #Therapeutic Antibodies

Read the Winter issue of DDW now

The Winter issue of Drug Discovery World (DDW) is out now and asks whether AI can deliver better immunotherapies for cancer and includes expert predictions on what to expect from the sector in 2024, alongside a supplement looking at SLAS2024 and an exclusive guide exploring therapeutic antibodies. Read More

#News

Conference microphone
#AI / data analytics / healthtech / informatics #Biotherapeutics #Events #Lab technology #SLAS2024

SLAS2024 speaker update: Is pharma’s commercial model dying?

DDW is delighted to announce the final speaker on its SLAS2024 Ignite Theater track ‘Innovation & technology: from lab to patient’, co-sponsored by Integra Biosciences and Hamamatsu Corporation. Dipanwita Das On Monday 5 February at 11.30am, Dipanwita Das, CEO and Co-founder of Sorcero,… Read More

#News

Genomics
#AI / data analytics / healthtech / informatics #Events #Genetics / genomics #Lifebit #Personalised medicine

What are the trends in genomics and precision medicine for 2024?

Leading experts in genomics, personalised medicine and drug discovery convened at the Precision Medicine Community Event in London to unveil the latest advancements shaping the future of healthcare. The event highlighted critical areas such as secure and diverse data access, genomic sequencing in newborns, building public… Read More

#News

Conference microphone
#AI / data analytics / healthtech / informatics #Biotherapeutics #Events #Lab technology #SLAS2024

SLAS2024 update: How tech is reducing failure rates in trials

Be sure to attend the Ignite Theater at SLAS2024 in Boston on 5 and 6 February 2024. Focused on the theme ‘Innovation & technology: from lab to patient’, the DDW-curated programme, sponsored by Integra Biosciences and Hamamatsu Corporation, will feature presentations from experts… Read More

#News

Conference microphone
#AI / data analytics / healthtech / informatics #Biotherapeutics #Events #Lab technology #SLAS2024

SLAS2024 update: New tech accelerates drug development

The SLAS Ignite Theater ‘Innovation & technology: from lab to patient’, co-sponsored by Integra Biosciences and Hamamatsu Corporation, will take place at SLAS2024 in Boston on 5 and 6 February 2024. Developed by DDW in partnership with SLAS, the programme will feature leading… Read More

#News